Evidence that a novel somatostatin receptor couples to an inward rectifier potassium current in AtT-20 cells

Neuroscience

Volumn 73, Issue 3, 1996, Pages 855-864

  Tallent, M ^a,b   Dichter, M A ^a   Reisine, T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

AtT 20 cells; inward rectifier potassium current; somatostatin antagonist; somatostatin receptor

Indexed keywords

BIM 23023; BIM 23027; CGP 23996; DEXTRO PHENYLALANYLPHENYLALANYLPHENYLALANYL DEXTRO TRYPTOPHYLLYSYLTHREONYLPHENYLALANYLTHREONINAMIDE; L 362855; L 363409; NC8 12; OCTREOTIDE; RECEPTOR SUBTYPE; SEGLITIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE RELEASE; HYPOPHYSIS CELL; MOUSE; NEUROTRANSMISSION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0030218924     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00079-6     Document Type: Article

References (50)

1. 1. Adler M., Sabol S. L., Busis N. and Pant H. C. (1989) Intracellular calcium and hormone secretion in clonal AtT-20/D16-16 anterior pituitary cells. Cell Calcium 10, 467-476.
2. 2. Bruno J., Yu Y., Song J. and Berlowitz M. (1992) Molecular cloning and functional expression of a novel brain somatostatin receptor. Proc. natn. Acad. Sci. U.S.A. 89, 11,151-11,155.
3. 3. Clark J. A., Liu L., Price M., Hersh B., Edelson M. and Pasternak G. W. (1989) Kappa opiate receptor multiplicity: evidence for two U50,448-sensitive kappal subtypes and a novel kappa3 subtype. J. Pharmac. exp. Ther. 251, 461-468.
4. 4. Fries J. L., Murphy W. A., Sueiras-Diaz J. and Coy D. H. (1982) Somatostatin antagonist analog decreases GH, insulin, and glucagon release in the rat. Peptides 3, 811-814.
5. 5. Golard A., Role L. W. and Siegelbaum S. A. (1993) Protein kinase C blocks somatostatin-induced modulation of calcium current in chick sympathetic neurons. J. Neurophysiol. 70, 1639-1642.
6. 6. Hamill O. P., Marty A., Neher E., Sakmann B. and Sigworth F. J. (1981) Improved patch-clamp technique for high resolution current recordings from cell and cell-free membrane patches. Pflügers Arch. 391, 85-100.
7. 7. Ikeda S. R. and Schofield G. C. (1989) Somatostatin cyclic octapeptide analogs which preferentially bind SOMa receptors block a calcium current in rat superior cervical ganglion neurons. Neurosci. Lett. 96, 283-288.
8. 8. Inoue M., Nakajima S. and Nakajima Y. (1988) Somatostatin induces an inward rectification in rat locus coeruleus neurons through a pertussis toxin sensitive mechanism. J. Physiol. 407, 177-198.
9. 9. Jones S. V. P. (1992) m4 Muscarinic receptor subtype activates an inwardly rectifying potassium conductance in AtT-20 cells. Neurosci. Lett. 147, 125-130.
10. 10. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G. and Wittig B. (1991) Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353, 43-48.
11. 11. Kleuss C., Scherubl H., Hescheler J., Schultz G. and Wittig B. (1992) Different β-subunits determine G-protein interaction with transmembrane receptors. Nature 358, 424-426.
12. 12. Koch B. D. and Schonbrunn A. (1988) Characterization of the cyclic AMP-independent actions of somatostatin in GH cells. J. biol. Chem. 263, 225-234.
13. + channel proteins. Nature 374, 135-141.
14. 14. Kubo Y., Reuveny E., Siesinger P. A., Jan Y. N. and Jan L. Y. (1993) Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel. Nature 364, 802-806.
15. 15. Law S. F., Manning D. and Reisine T. (1991) Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J. biol. Chem. 226, 17,885-17,897.
16. 16. Loshe M. J. (1993) Molecular mechanisms of membrane receptor desensitization. Biochim. biophys. Acta 1179, 171-188.
17. 17. Luini A., Lewis D. H., Guild S., Schofield G. and Weight F. F. (1986) Somatostatin, an inhibitor of ACTH secretion, decreases cytosolic free calcium and voltage-dependent calcium current in a pituitary cell line. J. Neurosci. 6, 3128-3132.
18. 18. Mahy N., Woolkalis M., Manning D. and Reisine T. (1988) Characteristics of somatostatin desensitization in the pituitary tumor cell line AtT-20. J. Pharmac. exp. Ther. 246, 779-785.
19. 19. Martin J.-L., Chesselet M.-F., Raynor K., Gonzales C. and Reisine T. (1991) Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41, 581-593.
20. 20. McCoy K. W., Rotto D. M., Rybicki K. J. and Kaufman M. P. (1988) Attenuation of reflex pressor response to muscular contraction by an antagonist to somatostatin. Circulation Res. 62, 18-24.
21. 21. Mihara S., North R. A. and Suprenant A. (1987) Somatostatin increases an inwardly rectifying potassium conductance in guinea pig submucosa plexus neurones. J. Physiol. 390, 335-355.
22. 22. North R. A. (1993) Opioid actions on membrane ion channels. In Opioids I (ed. Hertz A.), pp. 773-796. Springer, Berlin.
23. 23. O'Carroll A.-M., Lolait S., Konig M. and Mahan L. (1992) Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Molec. Pharmac. 42, 939-946.
24. 24. Ohmura T., Nishio M., Kigoshi S. and Muramatsu I. (1990) Somatostatin decreases the calcium inward current in guinea-pig atria. Br. J. Pharmac. 99, 587-591.
25. 25. Patel Y. C., Panetta R., Escher E., Greenwood M. and Srikant C. B. (1994) Expression of multiple somatostatin receptor genes in AtT-20 cells. J. biol. Chem. 269, 1506-1509.
26. 26. Pennefather P. S., Heisler S. and MacDonald J. F. (1988) A potassium conductance contributes to the action of somatostatin-14 to suppress ACTH secretion. Brain Res. 444, 346-350.
27. 27. Rasolonjanahary R., Sevenet T., Voegelein F. G. and Kordon C. (1995) Psycholeine, a natural alkaloid extracted from Psychotria oleoides, acts as a weak antagonist of somatostatin. Eur. J. Pharmac. 285, 19-23.
28. 28. Raynor K., Coy D. C. and Reisine T. (1992) Analogues of somatostatin bind selectively to brain somatostatin receptor subtypes. J. Neurochem. 59, 1241-1250.
29. 29. Raynor K., Murphy W. A., Coy D. A., Taylor J. E., Moreau J.-P., Yasuda K., Bell G. I. and Reisine T. (1993) Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Molec. Pharmac. 43, 838-844.
30. 30. Raynor K., O'Carroll A.-M., Kong H., Yasuda K., Mahan L. C., Bell G. I. and Reisine T. (1993) Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Molec. Pharmac. 44, 385-392.
31. 31. Raynor K. and Reisine T. (1992) Differential coupling of somatostatin1 receptors to adenylyl cyclase in the rat striatum vs. the pituitary and other regions of the rat brain. J. Pharmac. exp. Ther. 260, 841-848.
32. 32. Raynor K., Wang H.-L. and Reisine T. (1991) Subtypes of brain somatostatin receptors couple to multiple cellular effector systems. Molec. Pharmac. 40, 248-253.
33. 33. Reisine T. (1984) Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and ACTH release. J. Pharmac. exp. Ther. 229, 14-20.
34. 34. Reisine T. (1985) Multiple mechanisms of somatostatin inhibition of adrenocorticotropin release from mouse anterior pituitary tumor cells. Endocrinology 116, 2259-2266.
35. 35. Reisine T., Wang H.-L. and Guild S. (1988) Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population. J. Pharmac. exp. Ther. 245, 225-231.
36. 36. Rens-Domiano S., Law S. F., Yamada Y., Seino S., Bell G. I. and Reisine T. (1992) Pharmacological properties of two cloned somatostatin receptors. Molec. Pharmac. 42, 28-34.
37. ++ currents by LHRH and somatostatin in a pituitary cell line. Eur. molec. Biol. Org. J. 7, 1627-1633.
38. 38. Rossowski W. J. and Coy D. H. (1993) Potent inhibitory effects of type-4 receptor selective somatostatin analogs on insulin release. Biochem. biophys. Res. Commun. 197, 366-371.
39. 39. Rossowski W. J. and Coy D. H. (1994) Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. Biochem. biophys. Res. Commun. 205, 341-346.
40. ++ currents in an insulin-secreting cell line (RINmSf). J. biol. Chem. 266, 18,025-18,033.
41. 41. Smith S. J. and Augustine G. J. (1988) Calcium ions, active zones and synaptic transmitter release. Trends Neurosci. 11, 458-464.
42. 42. Spencer G. S. G. and Hallet K. G. (1985) Somatostatin antagonist analogue stimulates growth in rats. Life Sci. 37, 27-30.
43. 43. Spengler D., Waeber C., Pantaloni C., Hoisboer F., Bockaert J., Seeburg P. H. and Journot L. (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365, 170-175.
44. 44. Suprenant A.-M. (1982) Correlation between electrical activity and ACTH/β-endorphin secretion in mouse pituitary tumor cells. J. Cell Biol. 95, 559-566.
45. 45. Suprenant A.-M., Horstman D. A., Akbarali H. and Limbird L. E. (1992) A point mutation of the alpha2-adreno-receptor that blocks coupling to potassium but not calcium currents. Science 257, 977-980.
46. ++ current in the pituitary cell line AtT-20. Neuroscience 71, 1073-1081.
47. 47. Tatsumi H., Costa M., Schimerlik M. and North R. A. (1990) Potassium conductance increased by noradrenaline, opioids, somatostatin, and G-proteins: whole cell recordings from the guinea pig submucous neurons. J. Neurosci. 10, 1675-1682.
48. 48. Tran V. T., Beal M. F. and Martin J. B. (1985) Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science 228, 492-494.
49. 49. Yasuda K., Rens-Domiano S., Breder C. D., Law S. F., Saper C. B., Reisine T. and Bell G. I. (1992) Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylycyclase. J. biol. Chem. 267, 20,422-20,428.
50. iα-subunits. Nature 336, 680-682.